Loading decisions…
Loading decisions…
16,110 vetted Board decisions for Prostate cancer.
The Veteran's claim for accrued benefits based on service connection for prostate, lung and brain cancer due to herbicide exposure is being remanded for additional development as the appellant wishes to determine how her claim should be construed.
The Board has determined that the Veteran's prostate cancer is incurred in active service, and his claim for an acquired psychiatric disorder is granted.
The Veteran's claims for service connection for prostate cancer, malaria, and tinnitus were denied. His claim for compensation under 38 U.S.C.A. � 1151 for a hip replacement was also denied.
The Board has remanded the case for additional development to determine if the Veteran was assigned to temporary duty in the Republic of Vietnam during his service, which could potentially support a claim for secondary service connection for prostate cancer due to herbicide exposure.
The Board has determined that the Veteran's prostate cancer is no longer active as of May 18, 2015 and thus a 100% rating should be assigned until at least six months after any surgical or therapeutic procedures.
The Veteran's claim for TDIU is being remanded due to the need for additional development, including obtaining records from SSA and VA/VA clinics, as well as any private treatment records. A new VA examination will also be scheduled.
The Board found that the Veteran's prostate cancer was not incurred in or aggravated by service, and may not be presumed to have been incurred therein due to exposure to contaminated water at Camp Lejeune.
The Board has remanded the case for a Travel Board hearing and further development.
The Veteran's appeal was dismissed due to his death.
The Veteran's appeals for higher ratings for hearing loss, service connection for prostate cancer, and service connection for leukemia have been dismissed due to the death of the appellant.
The Board finds that the Veteran's residuals of prostate cancer are service-connected due to exposure to herbicides during military service. The acquired psychiatric disorder (depression) is not service-connected as there is no evidence of a diagnosed condition. Bilateral hearing loss and tinnitus are not service-connected as they are more likely related to presbycusis rather than noise exposure in service.
The Veteran is seeking service connection for prostate cancer and diabetes mellitus type 2, as secondary to herbicide exposure in Vietnam. The appeal is being remanded due to the need to verify his assertions of in-country service.
The Board finds that the Veteran's service in the Republic of Vietnam as part of his duties during service, including a temporary duty assignment, is credible. Therefore, exposure to herbicides is conceded and service connection for prostate cancer due to such exposure is granted.
The Veteran's prostate cancer and erectile dysfunction have been restored to a 100% disability rating.,The issue of an increased rating for the residuals of prostate cancer with radical prostatectomy is moot as the Veteran is currently receiving a 100% rating.
The Veteran has been granted service connection for prostate cancer, coronary artery disease, and erectile dysfunction. The Board found that these conditions are related to his military service.,For the remaining issues, including hypertension and GERD, additional medical records need to be obtained and an addendum opinion from the September 2012 VA examiner is required.
The Veteran's appeal is being remanded for a more contemporaneous and complete examination by a vocational specialist to assess the impact of his service-connected disabilities on his employability. The case will be readjudicated after this development.
The Board finds that March 23, 2006 is the correct effective date for the award of service connection for prostate cancer because there is no evidence showing an earlier claim. The Veteran's psychiatric disability and asthma claims are remanded for additional development.
The Veteran's erectile dysfunction is not manifested by penile deformity, and therefore does not warrant a compensable disability rating.
The Veteran's prostate cancer residuals are rated at a 40 percent rating effective January 1, 2013. The Board finds that the evidence supports this rating and additional development is needed to determine if an even higher rating is warranted.
The Board found that the Veteran's prostate cancer is not related to his active service and denied his claim for service connection.
← Back to Prostate cancer overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.